BIOMAT Database Logo BIOMAT Database Logo

Pharmacological profile of Ro 23-3544, a new aerosol active leukotriene receptor antagonist. 1987

M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Department of Pharmacology and Chemotherapy, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110.

UI MeSH Term Description Entries
D008170 Lung Compliance The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562) Compliance, Lung,Compliances, Lung,Lung Compliances
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D018077 Receptors, Leukotriene Cell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4. Leukotriene Receptors,Receptors, SRS-A,SRS-A Receptors,Leukotriene Receptor,Receptors, Leukotrienes,SRS-A Receptor,Slow Reacting Substance of Anaphylaxis Receptors,Slow Reaction Substance of Anaphylaxis Receptors,Leukotrienes Receptors,Receptor, Leukotriene,Receptor, SRS-A,Receptors, SRS A,SRS A Receptor,SRS A Receptors

Related Publications

M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
[Thiophene as a structural element of physiologically active substances. 20. Thiophene analogs of the leukotriene D4 antagonist Ro 23-3544].
December 1992, Archiv der Pharmazie,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
L-648,051: an aerosol active leukotriene D4 receptor antagonist.
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Allergic contact dermatitis--description of a test model for topical anti-inflammatories with particular reference to the leukotriene-C4 antagonist Ro-23-3544.
January 1991, Archives of dermatological research,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.
April 1994, Inflammation,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
November 2004, European journal of pharmacology,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Cardiovascular effects of N-methyl leukotriene C4, a nonmetabolizable leukotriene C4 analogue, and the antagonism of leukotriene-induced hypotension by Ro 23-3544, in the American bullfrog, Rana catesbeiana.
March 1995, Canadian journal of physiology and pharmacology,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of etintidine, a new histamine H2-receptor antagonist.
May 1986, Archives internationales de pharmacodynamie et de therapie,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of MEN91507, a new CysLT(1) receptor antagonist.
September 2002, European journal of pharmacology,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
April 1996, British journal of pharmacology,
M O'Donnell, and A F Welton, and H Crowley, and D Brown, and R Garippa, and N Cohen, and G Weber, and B Banner, and R J Lopresti
Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.
September 1999, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!